7.4. adjuvant intravesical treatment. although turb eradicate tat1 tumour completely, tumours commonly recur progress mibc. high variability 3-month recurrence rate indicates turb incomplete provokes recurrences high percentage patients . therefore necessary consider adjuvant therapy patients.